MedTrace Logo

Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation

NCT02626871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2017-05-04

No results posted yet for this study

Summary

The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.

Conditions

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Oulu University Hospital

    collaborator OTHER

  • Kuopio University Hospital

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Tuomas Kiviniemi, MD, PhD · Turku University Hospital

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626871 on ClinicalTrials.gov